ThrombUS+ Horizon Europe Project

Deep vein thrombosis (DVT) poses a significant health risk, with potentially life-threatening consequences when left undetected. ThrombUS+ is set to redefine DVT care with an ambitious mission to develop an innovative wearable diagnostic device for point-of-care, operator-free, continuous monitoring. Our interdisciplinary approach centers around creating a novel wearable diagnostic device utilizing autonomous, AI-driven DVT detection. This groundbreaking device incorporates wearable ultrasound hardware, impedance plethysmography, and light reflection rheography for immediate clot detection. Activity and physiological measurements will continuously assess DVT risk, supporting prevention through serious gaming. An intelligent decision support unit will provide real-time monitoring and alerts, with extended reality guiding users for optimal device utilization. With a duration of 42 months, ThrombUS+ kicks off on January 1, 2024, and concludes on June 30, 2027. The project has 18 partners from Greece, Lithuania, France, Germany, the USA, Italy, Finland, and Spain. The Horizon Europe Innovation Action funds the venture with 9.5 M€. ThrombUS+ will leverage big datasets collected through three large-scale clinical studies for AI training. Validation will be carried out in clinical settings through one early feasibility study and one multi-center clinical trial. Join us on this transformative journey as ThrombUS+ pioneers wearable continuous point-of-care monitoring, risk estimation, and prevention for Deep Vein Thrombosis. **Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Horizon EU project. Neither the European Union nor the granting authority can be held responsible for them.